Thomas Wessel

2016

In 2016, Thomas Wessel earned a total compensation of $874.4K as Chief Medical Officer at Flex Pharma, a 49% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$138,329
Option Awards$316,061
Salary$406,850
Other$13,187
Total$874,427

Wessel received $406.9K in salary, accounting for 47% of the total pay in 2016.

Wessel also received $138.3K in non-equity incentive plan, $316.1K in option awards and $13.2K in other compensation.

Rankings

In 2016, Thomas Wessel's compensation ranked 8,875th out of 14,075 executives tracked by ExecPay. In other words, Wessel earned more than 36.9% of executives.

ClassificationRankingPercentile
All
8,875
out of 14,075
37th
Division
Manufacturing
3,437
out of 5,489
37th
Major group
Chemicals And Allied Products
1,165
out of 1,895
39th
Industry group
Drugs
918
out of 1,538
40th
Industry
Pharmaceutical Preparations
732
out of 1,176
38th
Source: SEC filing on April 19, 2017.

Wessel's colleagues

We found two more compensation records of executives who worked with Thomas Wessel at Flex Pharma in 2016.

2016

Christoph Westphal

Flex Pharma

Chief Executive Officer

2016

Robert Hadfield

Flex Pharma

General Counsel

You may also like